SW
Therapeutic Areas
Xbrane Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ximluci® (Xlucane™) | Neovascular (wet) Age-Related Macular Degeneration (AMD) (ranibizumab biosimilar) | BLA Resubmission |
| Xdivane™ | Cancer (biosimilar, originator unspecified) | Pivotal Trial |
| Spherotide | Complex generic (difficult-to-manufacture product) | Unknown |